AMANDA HANOR: Open Payments
NPI 1831605773 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,699 in 95 payments from 13 companies in 2025. Trend: 2023 $2,168 · 2024 $2,275 · 2025 $1,699
Food & beverage: $1,387Education: $312
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 27 | $407 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 7 | $239 |
| ABBVIE INC. | 13 | $236 |
| Galderma Laboratories, L.P. | 13 | $199 |
| PFIZER INC. | 15 | $179 |
| UCB, Inc. | 5 | $130 |
| Novartis Pharmaceuticals Corporation | 5 | $104 |
| LEO Pharma Inc. | 3 | $53 |
| Lilly USA, LLC | 2 | $50 |
| E.R. Squibb & Sons, L.L.C. | 2 | $30 |
Products named: TREMFYA, SKYRIZI, NEMLUVIO, CIBINQO, Bimzelx, COSENTYX, ILUMYA, TALTZ.
Industry payments across NV — which companies pay providers there.
